The North America Fusion Biopsy Market is expected to witness market growth of 10.7% CAGR during the forecast period (2020-2026).
A Fusion biopsy system combines MRI ultrasound along with biopsy system for a better view. Fusion biopsy is also termed as fusion guided biopsy. Moreover, biopsy infers taking the tissue sample from the body then examines the report and detect it in the best possible manner. When test previously done in case of any prostrate related problems and if that test shows an anomaly in certain areas of the sample; then doctors recommend for biopsy.
The factors that drive the growth of the Fusion Biopsy System Market comprise the rising demand, increasing cancer disorders, changes brought into the standard of living, a more sedentary lifestyle, and at the same time increasing awareness among people. Fusion Biopsy System Market is further characterized based on geography and applications. On the basis of End Use, Fusion Biopsy System Market is categorized into Hospitals, Diagnostic Centers, and Ambulatory Surgical Center (ASCs).
The government initiatives are also increasing in terms of spreading awareness, funding research, and conducting mass screening programs that are related to prostate cancer therefore they are predicted to play a vital role in the growth of the fusion biopsy market. For example, the U.S. federal government is investing millions of dollars annually in prostate cancer research from the Prostate Cancer Research Program (PCRP), and the National Institute of Health (NIH). The venture is made to progress the advancement in prostate cancer care, its diagnostic and treatment technologies.
Based on End Use, the market is segmented into Diagnostic centers, Hospitals and Ambulatory care centers. Based on Route, the market is segmented into Transperineal and Transrectal. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., Hitachi, Ltd., Baxter International, Inc. (MedCom), Esaote SpA, Eigen, KOELIS, Inc., Focal Healthcare, Inc. and UC-Care Medical Systems Ltd.
Scope of the Study
Market Segmentation:
By End Use
By Route
By Country
Companies Profiled
Unique Offerings from the Publisher
A Fusion biopsy system combines MRI ultrasound along with biopsy system for a better view. Fusion biopsy is also termed as fusion guided biopsy. Moreover, biopsy infers taking the tissue sample from the body then examines the report and detect it in the best possible manner. When test previously done in case of any prostrate related problems and if that test shows an anomaly in certain areas of the sample; then doctors recommend for biopsy.
The factors that drive the growth of the Fusion Biopsy System Market comprise the rising demand, increasing cancer disorders, changes brought into the standard of living, a more sedentary lifestyle, and at the same time increasing awareness among people. Fusion Biopsy System Market is further characterized based on geography and applications. On the basis of End Use, Fusion Biopsy System Market is categorized into Hospitals, Diagnostic Centers, and Ambulatory Surgical Center (ASCs).
The government initiatives are also increasing in terms of spreading awareness, funding research, and conducting mass screening programs that are related to prostate cancer therefore they are predicted to play a vital role in the growth of the fusion biopsy market. For example, the U.S. federal government is investing millions of dollars annually in prostate cancer research from the Prostate Cancer Research Program (PCRP), and the National Institute of Health (NIH). The venture is made to progress the advancement in prostate cancer care, its diagnostic and treatment technologies.
Based on End Use, the market is segmented into Diagnostic centers, Hospitals and Ambulatory care centers. Based on Route, the market is segmented into Transperineal and Transrectal. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., Hitachi, Ltd., Baxter International, Inc. (MedCom), Esaote SpA, Eigen, KOELIS, Inc., Focal Healthcare, Inc. and UC-Care Medical Systems Ltd.
Scope of the Study
Market Segmentation:
By End Use
- Diagnostic centers
- Hospitals
- Ambulatory care centers
By Route
- Transperineal
- Transrectal
By Country
- US
- Canada
- Mexico
- Rest of North America
Companies Profiled
- Koninklijke Philips N.V.
- Hitachi, Ltd.
- Baxter International, Inc. (MedCom)
- Esaote SpA
- Eigen
- KOELIS, Inc.
- Focal Healthcare, Inc.
- UC-Care Medical Systems Ltd.
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. North America Fusion Biopsy Market by End Uses
Chapter 5. North America Fusion Biopsy Market by Route
Chapter 6. North America Fusion Biopsy Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Koninklijke Philips N.V.
- Hitachi, Ltd.
- Baxter International, Inc. (MedCom)
- Esaote SpA
- Eigen
- KOELIS, Inc.
- Focal Healthcare, Inc.
- UC-Care Medical Systems Ltd.
Methodology
LOADING...
